Stay updated on Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page.

Latest updates to the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1 while the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content and navigation. This indicates the study information is temporarily inaccessible to users.SummaryDifference16%

- Check56 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata. This does not modify the study details or the information presented to users.SummaryDifference0.0%

- Check77 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5. This indicates a minor update to the page's backend or presentation, without changing the study information or user-facing content.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, signaling a new page version. The change represents a backend update to the page's release/version rather than a substantive modification to study information.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page.